Pathway enrichment analysis linked CK18 elevation to processes involved in NAFLD pathogenesis, including insulin resistance, TNF‐α‐mediated inflammation, and apoptosis (Figure S1), which supported the biological plausibility of CK18 participation in systemic metabolic and inflammatory pathways. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatotic liver disease.